Volume 20, Number 12—December 2014
Circulation of Reassortant Influenza A(H7N9) Viruses in Poultry and Humans, Guangdong Province, China, 2013
Views: Views equals page views plus PDF downloadsMetric Details
Highlight and copy the desired format.
|EID||Ke C, Lu J, Wu J, Guan D, Zou L, Song T, et al. Circulation of Reassortant Influenza A(H7N9) Viruses in Poultry and Humans, Guangdong Province, China, 2013. Emerg Infect Dis. 2014;20(12):2034-2040. https://dx.doi.org/10.3201/eid2012.140765|
|AMA||Ke C, Lu J, Wu J, et al. Circulation of Reassortant Influenza A(H7N9) Viruses in Poultry and Humans, Guangdong Province, China, 2013. Emerging Infectious Diseases. 2014;20(12):2034-2040. doi:10.3201/eid2012.140765.|
|APA||Ke, C., Lu, J., Wu, J., Guan, D., Zou, L., Song, T....Zhang, Y. (2014). Circulation of Reassortant Influenza A(H7N9) Viruses in Poultry and Humans, Guangdong Province, China, 2013. Emerging Infectious Diseases, 20(12), 2034-2040. https://dx.doi.org/10.3201/eid2012.140765.|
Influenza A(H7N9) virus emerged in eastern China in February 2013 and continues to circulate in this region, but its ecology is poorly understood. In April 2013, the Guangdong Provincial Center for Disease Control and Prevention (CDC) implemented environmental and human syndromic surveillance for the virus. Environmental samples from poultry markets in 21 city CDCs (n = 8,942) and respiratory samples from persons with influenza-like illness or pneumonia (n = 32,342) were tested; viruses isolated from 6 environmental samples and 16 patients were sequenced. Sequence analysis showed co-circulation of 4 influenza A(H7N9) virus strains that evolved by reassortment with avian influenza A(H9N2) viruses circulating in this region. In addition, an increase in human cases starting in late 2013 coincided with an increase in influenza A H7 virus isolates detected by environmental surveillance. Co-circulation of multiple avian influenza viruses that can infect humans highlights the need for increased surveillance of poultry and potential environmental sources.
Human infection with a novel avian-origin influenza A(H7N9) virus was first identified in eastern China in February 2013, and a major outbreak occurred from the end of March through the beginning of May (1,2). Risk factors identified for a severe course of illness were older age (>65 years) and underlying illnesses, including hypertension and chronic lung diseases, but the full spectrum of illness associated with H7N9 virus remains to be determined (3). Molecular characterization has shown that the H7N9 virus emerged by reassortment between H7, N9, and H9N2 avian influenza viruses from the Yangzi River Delta region; this reassortment likely occurred in eastern China in early 2012 (2,4,5). Because infection with H7N9 virus does not cause overt disease in poultry, the spread of infection can be insidious, and the exact modes and extent of geographic spread of the virus remain unknown. Birds commonly used for egg and meat production in China differ in their susceptibility, levels of virus shedding, and ability to transmit the virus; data from experimental infections indicate that quail and chickens are possible candidates for virus transmission (6). Detailed analysis of viruses from human patients showed evidence for diversification through reassortment of the originally detected viruses with strains from poultry in the same geographic region (7). Infection of humans is linked to exposure to poultry or to environments where poultry are present; closure of live poultry markets (LPMs) has had a measurable effect on controlling the spread of infection (8,9).
After H7N9 virus was initially detected in eastern China, the Guangdong Provincial Center for Disease Control and Prevention (CDC) implemented environmental surveillance and syndromic surveillance in humans. After H7N9 virus infection in humans was reported, enhanced sentinel hospital surveillance and environmental sampling programs were implemented to identify possible cases and analyze the evolution of the virus. The first case of human infection with H7N9 virus in Guangdong was confirmed in a patient with severe pneumonia on August 10, 2013. This case-patient was a 51-year-old female poultry worker at a local LPM in Huizhou city in Guangdong Province. No other cases were reported until October 2013, when a wave of cases began in several provinces, including Guangdong. We present results of ongoing environmental and human syndromic surveillance for H7N9 virus circulation in Guangdong Province, as well as virologic analyses related to the natural history of this outbreak.
Syndromic Surveillance in Humans
Since April 16, 2013, enhanced surveillance for influenza A(H7N9) virus has been conducted in 28 sentinel hospitals and 23 collaborating laboratories in 21 cities in Guangdong Province, China. All specimens are first tested for avian influenza A virus; specimens with positive results are then further tested in the laboratories of the 21 city CDCs for subtypes H5, H7, and H9 by using commercial real-time reverse transcription PCR (RT-PCR) (Liferiver, Shanghai ZJ Bio-Tech, Shanghai, China). Results are further verified at the Guangdong Provincial CDC. H7-positive specimens are tested for N9 gene segments by using real-time RT-PCR (2). H7N9-positive swab materials and sputum samples are then blindly passaged for 2 or 3 generations in 9- or 10-day-old embryonated chicken eggs for virus isolation. Hemagglutination-positive allantoic fluids are collected, and viruses are subtyped by hemagglutination and neuraminidase inhibition (HI and NI) assays by using a panel of reference antiserum, as described by Huang et al. (10). Standard precautions are taken to avoid cross-contamination of specimens. All H7 influenza viruses isolated from patients undergo complete genome sequencing.
In April 2013, the Guangdong Provincial CDC launched an environmental surveillance program to monitor for avian influenza viruses in LPMs. Environmental samples were collected from LPMs in Guangdong Province during April 15, 2013–February 28, 2014. Each week during April 15–May 31, 2013, twenty environmental samples per market were collected from selected markets in 21 cities at the prefecture level. The environmental sampling was done by collecting wet-swab specimens from poultry feces, chicken epilator surfaces, chopping board surfaces, cage surfaces, and sewage. If a human H7N9 case was confirmed and the case-patient had exposure in an LPM, >20 environmental samples would be collected from that market.
Samples were collected from poultry feces by swabbing the surfaces of the chicken epilator, chopping boards, and cages 4–8 times with separate cotton-tipped swabs (Copan Italia, Brescia, Italy). The swabs were then inserted into a tube containing 3 mL of virus transport medium (Copan Italia) and stored at 4°C before shipping to the CDC laboratory. At arrival in the laboratory, samples were vortexed and swabs were discarded. Total RNA and DNA were extracted simultaneously from 200 μL supernatant of the sample by using the QIAamp minElute Virus Spin Kit (QIAGEN, Crawley, UK), according to the manufacturer’s instructions. Then, 5 μL of eluate was tested for influenza A; thereafter, testing for subtypes H5, H7, and H9 was done by commercial real-time reverse transcription PCR (RT-PCR) (Liferiver, Shanghai ZJ Bio-Tech). H7-positive specimens were further subjected to N9 gene-specific RT-PCR. Dual positive samples were blindly passaged for 2–3 generations in 9- to 10-day-old embryonated chicken eggs for virus isolation. Hemagglutinin (HA)–positive isolates were collected and further subtyped by HI and NI assays using a panel of reference antiserum, as described by Huang et al. (10). Standard precautions were taken to avoid cross-contamination of specimens. Monoinfluenza virus infection (without mixed infection of other subtypes) was further confirmed by RT-PCR before whole-genome sequencing. All H7N9 isolates from LPMs were subjected to complete genome sequencing, as were 7 H9 influenza viruses that were isolated from different LPMs during May–December 2013.
Whole-Genome Deep Sequencing
For all selected isolates, all 8 gene segments (HA, neuraminidase [NA], nucleoprotein [NP], polymerase basic 1 [PB1] and 2 [PB2], polymerase acidic [PA], matrix [M], and nonstructural [NS]) were sequenced by using a next-generation sequencing strategy for influenza A virus sequencing with the Ion PGM System and PathAmp FluA Reagents (Life Technologies, Carlsbad, CA, USA). Viral RNA extraction was performed by using the QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, Germany). Reverse transcription PCR amplification of all 8 gene segments were performed by using PathAmp Flu A Preamplification Reagents (Life Technologies). Amplicons were purified and quantitated by using the Ampure XP purification kit (Beckman, Brea, CA, USA). The genomic libraries were prepared with the Ion Xpress Plus Fragment Library Kit (Life Technologies). Enzymatic fragmentation was used for the 200-bp read protocol with a 10-min incubation time. Samples were assigned barcodes by using the Ion Xpress Barcode Adapters 1–32 Kit (Life Technologies). Automated template preparation was performed by using the Ion OneTouch 2 System (Ion PGM Template OT2 200 Kit; Life Technologies). Final sequencing was performed with the Ion PGM Sequencing 200 Kit v2 (Life Technologies) using the Ion 316 Chip V2.
Genome Sequence Alignment
Genome sequence assembly was done with the pathogen analysis program of the Ion PGM server (Life Technologies). Multiple sequence alignment against previously published complete genome sequences of H7N9 and H9N2 viruses was performed by using ClustalW (http://www.clustal.org) and BioEdit software version 7.14 (http://www.mbio.ncsu.edu/bioedit/bioedit.html). The whole-genome sequences were submitted to GISAID (http://www.gisaid.org; accession nos. EPI148417 and EPI151429–151437).
Phylogenetic Analysis and Data Visualization
Maximum-likelihood trees were estimated for all 8 gene segments by using MEGA version 5.2 (http://www.megasoftware.net) with the general time reversible + Γ model (11). To assess the robustness of individual nodes on phylogenetic trees, a bootstrap resampling process (1,000 replications) and the neighbor-joining method were used.
The initial trees were constructed in PhyML by using general time reversible + I + Γ4 as the evolutionary model (12). GARLI (https://code.google.com/p/garli/) was run on the best tree from PhyML for 1 million generations to optimize tree topology and branch lengths.
A total of 34,342 samples from patients with pneumonia or influenza-like illness from 21 cities in Guangdong Province were tested during April 2013–February 2014. Of these, samples from 81 patients from 10 cities tested positive for influenza A(H7N9) virus. With the exception of 1 case confirmed in August 2013, all other cases were found starting in October 2013. In total, 6 cases were confirmed in 2013 and 75 in early 2014.
Patient characteristics are summarized in Table 1. Most patients were male, and the median age of all patients was 52 years. Of the 81 patients, 70 (84%) had severe illness, which likely reflected the design of the surveillance (hospitalized patients). Twenty-two (27%) patients died; 14 remained hospitalized as of May 2014, and 45 had recovered. Overall, 73 patients (90.1%) reported poultry contact (Table 1).
A total of 8,942 swab samples from LPMs were collected and screened in laboratories of city CDCs at the prefecture level and at Guangdong Provincial CDC (2). Overall, 425 samples (4.8%) from 13 cities tested positive for H7 viruses, and 1,050 (11.8%) from 19 cities were positive for H9 viruses. The prevalence of viral genes in regions with positive findings ranged from 1%–14% of swab samples for H7 viruses and 1.7%–27.5% for H9. The H9 detection rate remained ≈12% throughout the year, except during June, when only 4% of samples tested positive. H9 viruses were detected throughout Guangdong Province (19 of the 21 cities; Figure 1, panel A). In contrast, only 1 H7-virus positive specimen was detected during March–September 2013 (in Meizhou in April), but detections of H7 viruses increased beginning in October: from 1 site in October, 3 in November, 8 in January, and 7 in February. H7 viruses were detected in the Pearl River Regions of Guangdong Province (Figure 1, panel B). Human cases were found in 10 of the 13 cities where environmental samples were positive for H7, and in 0 of the 8 cities where no H7 viruses were found in environmental samples (Figure 1).
Whole-genome sequences were determined for the H7N9 virus isolates from 16 patients and 6 environmental samples and for the 9 H9 viruses collected during environmental surveillance. Phylogenetic trees were constructed for each internal gene segment against all currently available H7N9 and H9N2 virus sequences from the National Center for Biotechnology Information and GISAID. Phylogenetic analysis of the whole-genome sequences showed the clear separation of PB2, PB1, and NS gene sequences of the Guangdong patient isolates from those detected from patients from eastern China (Figure 2).
Gene sequences on the same branch were reviewed to identify region of origin; these sequences matched internal genes from H9N2 viruses detected in southern China (Technical Appendix [PDF - 562 KB - 9 pages]). M genes of all viruses clustered with the genes detected in viruses from the main H7N9 virus cluster in 2013, whereas diversity was seen in the PA (main 2013 variant and 2 additional lineages) and NP (2 lineages) genes. Combined, the H7N9 virus isolates that were sequenced appeared to represent at least 4 different reassortants (Table 2).
HA and NA genes
The HA and NA genes of all H7N9 isolates from Guangdong Province we analyzed had high sequence identity (98.2%–99.7%) to viruses from other regions of China detected throughout 2013. However, the Guangdong Province isolates branched off and clustered with strains detected in Hong Kong during 2014 (Technical Appendix [PDF - 562 KB - 9 pages]).
The outbreak of influenza A(H7N9) virus infection in humans in Guangdong Province that started in late 2013 coincided with the emergence of influenza A H7 viruses in LPMs as determined by environmental surveillance. The strong association between detection of human H7N9 cases and presence of H7 viruses in LPMs confirms that these market environments are sources of human exposure (8,13). A key question is how the virus has been spreading in China since the initial emergence in eastern China. A risk-mapping approach taking into account LPM locations, human population density, cropland irrigation, and meteorologic conditions listed central Guangdong Province as a high-risk area (defined as probability of the presence of influenza A[H7N9] viruses) (14). Little is known, however, about how H7N9 virus spreads and the prevalence of infection in commercial poultry flocks.
The data from our study suggest sources of human infection in Guangdong Province are local. All sequenced viruses had evolved from the original strains through genetic reassortment with internal genes originating from influenza A(H9N2) viruses commonly found in southern China. The HA sequences of these viruses formed a distinct branch in phylogenetic trees, which indicates that reassortment occurred some time ago and suggests that local sources of virus transmission in Guangdong Province have not been detected by surveillance activities. However, available data are insufficient to determine how long influenza A(H7N9) viruses have been circulating in this region.
The results from environmental surveillance suggest a higher prevalence of H9N2 virus in Guangdong Province poultry environments than in poultry environments in other regions of China (15). Because live poultry is the primary source of H7N9 virus (13,16–18), the coexistence with H9N2 in the same susceptible population generates appropriate conditions for the emergence of novel reassortant variants such as those shown in this study.
In summary, our findings indicate that multiple strains of H7N9 and H9N2 influenza viruses are circulating in poultry in Guangdong Province, creating an environment that is rich for reassortment of these viruses and that poses an ongoing risk for human infection. Continued and uncontrolled co-circulation of multiple avian and other influenza viruses that can infect humans pose a potential pandemic threat; increased animal surveillance and further study of the ecology of influenza viruses are essential.
Dr Ke is a senior scientist at Guangdong Provincial CDC, Guangdong, China, and is involved in the diagnosis and molecular epidemiology research of zoonoses and emerging infectious diseases.
This work was supported by 12th five-year-major projects of China’s Ministry of Public Health (grant no. 2012zx10004-213); the PREDICT Surveillance Animal Human Interface Project (grant no. Gvf: 06-09-057-02, to G.V.F.); and by the CASTELLUM grant, Dutch Ministry of Economic Affairs, Agriculture and Innovation (to M.K.).
- Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013;381:1916–25.
- Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888–97.
- Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277–85.
- Wu A, Su C, Wang D, Peng Y, Liu M, Hua S, Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe. 2013;14:446–52.
- Lam TT, Wang J, Shen Y, Zhou B, Duan L, Cheung CL, The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature. 2013;502:241–4.
- Pantin-Jackwood MJ, Miller PJ, Spackman E, Swayne DE, Susta L, Costa-Hurtado M, Role of poultry in spread of novel H7N9 influenza virus in China. J Virol. 2014;88:5381–90.
- Cui L, Liu D, Shi W, Pan J, Qi X, Li X, Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus. Nat Commun. 2014;5:3142.
- Ai J, Huang Y, Xu K, Ren D, Qi X, Ji H, Case-control study of risk factors for human infection with influenza A(H7N9) virus in Jiangsu Province, China, 2013. Euro Surveill. 2013;18:20510.
- Yu X, Jin T, Cui Y, Pu X, Li J, Xu J, Coexistence of influenza H7N9 and H9N2 in poultry linked to human H7N9 infection and their genome characteristics. J Virol. 2014;88:3423–31.
- Huang K, Zhu H, Fan X, Wang J, Cheung CL, Duan L, Establishment and lineage replacement of H6 influenza viruses in domestic ducks in southern China. J Virol. 2012;86:6075–83.
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.
- Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307–21.
- Han J, Jin M, Zhang P, Liu J, Wang L, Wen D, Epidemiological link between exposure to poultry and all influenza A(H7N9) confirmed cases in Huzhou city, China, March to May 2013. Euro Surveill. 2013;18:20481 .
- Fang LQ, Li XL, Liu K, Li YJ, Yao HW, Liang S, Mapping spread and risk of avian influenza A (H7N9) in China. Sci Rep. 2013;3:2722.
- Song R, Pang X, Yang P, Shu Y, Zhang Y, Wang Q, Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection. 2014;42:127–33.
- Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med. 2014;370:520–32.
- Bao CJ, Cui LB, Zhou MH, Hong L, Gao GF, Wang H. Live-animal markets and influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2337–9.
- Zhang W, Wang L, Hu W, Ding F, Sun H, Li S, Epidemiologic characteristics of cases for influenza A(H7N9) virus infections in China. Clin Infect Dis. 2013;57:619–20.
Technical AppendixCite This Article
- Page created: November 18, 2014
- Page last updated: November 18, 2014
- Page last reviewed: November 18, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)